Learn More
Invitrogen™ MAPK13 (p38 δ), rekombinantes, humanes Protein
MAPK13 (p38 delta) ist eine Serin-/Threonin-Kinase, die die Differenzierung von Keratinozyten reguliert.
Marke: Invitrogen™ PV3656
Weitere Details : Netto-Gewicht : 0.05250kg
Beschreibung
MAPK13 (p38 delta) wandelt eine Vielzahl von extrazellulären Signalen um, einschließlich Zytokin und Reaktionen auf Umwelteinflüsse.
Spezifikation
NP_002745 | |
Storage Buffer: 50mM Tris, pH 7.5, 150mM NaCl, 0.5mM EDTA, 0.02% Triton X-100, 2mM DTT, 50% glycerol Store at -80°C. At first use, aliquot and store at -80°C to avoid multiple freeze-thaws. |
|
Dry Ice | |
MAPK13 | |
Baculovirus | |
Full Length, Recombinant | |
Signal Transduction | |
Kinase Assay | |
46.2 kDa | |
MAPK13 (p38 δ) | |
His Tag |
Biochemical terbium phospho-specific activity, Biochemical phospho-specific activity (no antibody) | |
Ser⁄Thr Kinases: CMGC Group | |
LanthaScreen® Antibody, LanthaScreen® Substrate, Z'-LYTE™, Omnia® Bulk Substrate | |
mitogen-activated protein kinase 13 | |
Kinases & Inhibitors | |
Serine⁄Threonine Kinases | |
Human | |
5603 | |
10 μ g | |
MAP Kinase Family |